Washington, D.C. & Geneva, Switzerland — July 2026 Melhem Scientific and the United Nations Institute for Training and Research (UNITAR) are pleased to announce the signing of a Memorandum of Understanding (MOU), marking the beginning of a strategic collaboration focused on advancing global health, medical education, scientific research, innovation, and capacity building. This collaboration brings together the strengths of both organizations with a shared vision of expanding access to...

Launch clarifies how science, healthcare, philanthropy, advisory services, and investment work together under one enterprise vision. [Boston, MA] — Melhem Holdings today announced the launch of a new enterprise brand and a coordinated identity system for Melhem Holdings and its portfolio entities: Melhem Scientific, Melhem Pharmaceuticals, Melhem Foundation, Melhem Consultancy, and Melhem Investments. The initiative is designed to make a complex ecosystem feel clear, intentional, and...

New Shanghai-Based Enterprise to Accelerate Global Healthcare Innovation, Artificial Intelligence, Biotechnology, Digital Health, and Medical Technology Commercialization WASHINGTON, D.C. — Melhem Medical Technologies, Inc. (MMT), a United States-based healthcare innovation company, and Shanghai Xinhao International Trade Co., Ltd. (Xinhao), a leading China-based international trade and business development enterprise, today announced the signing of a strategic Joint Venture Memorandum of...